KYTX Kyverna Therapeutics, Inc.

NASDAQ

$6.81

Kyverna Therapeutics, Inc. (KYTX) Earnings News

Earnings press releases, previews and reviews for Kyverna Therapeutics, Inc. (KYTX), newest first.

Tuesday August 11, 2026 4:02 PM ET

Kyverna Therapeutics Reports Pipeline Progress and Second Quarter 2026 Financial Results

Tuesday May 12, 2026 4:02 PM ET

Kyverna Therapeutics Announces Initiation of Rolling SPS BLA Submission and Reports First Quarter 2026 Financial Results